SOLENO THERAPEUTICS INC - *W EXP 11/12/201 (SLNOW)

CUSIP: 834203135

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / *W EXP 11/12/201
Total 13F shares
801,633
Share change
+602,443
Total reported value
$297,000
Price per share
$0.12
Number of holders
3
Value change
+$273,000
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 834203135?
CUSIP 834203135 identifies SLNOW - SOLENO THERAPEUTICS INC - *W EXP 11/12/201 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SOLENO THERAPEUTICS INC - *W EXP 11/12/201 (SLNOW) as of Q1 2018

As of 31 Mar 2018, SOLENO THERAPEUTICS INC - *W EXP 11/12/201 (SLNOW) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 801,633 shares. The largest 3 holders included 683 Capital Management, LLC, Vivo Capital, LLC, and UBS Group AG. This page lists 3 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.